322 related articles for article (PubMed ID: 19028704)
1. Hormone-dependent effects of FGFR2 and MAP3K1 in breast cancer susceptibility in a population-based sample of post-menopausal African-American and European-American women.
Rebbeck TR; DeMichele A; Tran TV; Panossian S; Bunin GR; Troxel AB; Strom BL
Carcinogenesis; 2009 Feb; 30(2):269-74. PubMed ID: 19028704
[TBL] [Abstract][Full Text] [Related]
2. Replication of five GWAS-identified loci and breast cancer risk among Hispanic and non-Hispanic white women living in the Southwestern United States.
Slattery ML; Baumgartner KB; Giuliano AR; Byers T; Herrick JS; Wolff RK
Breast Cancer Res Treat; 2011 Sep; 129(2):531-9. PubMed ID: 21475998
[TBL] [Abstract][Full Text] [Related]
3. Genome-Wide Association Studies (GWAS) breast cancer susceptibility loci in Arabs: susceptibility and prognostic implications in Tunisians.
Shan J; Mahfoudh W; Dsouza SP; Hassen E; Bouaouina N; Abdelhak S; Benhadjayed A; Memmi H; Mathew RA; Aigha II; Gabbouj S; Remadi Y; Chouchane L
Breast Cancer Res Treat; 2012 Oct; 135(3):715-24. PubMed ID: 22910930
[TBL] [Abstract][Full Text] [Related]
4. Genetic variants in FGFR2 and TNRC9 genes are associated with breast cancer risk in Pakistani women.
Mazhar A; Jamil F; Bashir Q; Ahmad MS; Masood M; Tanvir I; Rashid N; Waheed A; Afzal MN; Tariq MA
Mol Med Rep; 2016 Oct; 14(4):3443-51. PubMed ID: 27572905
[TBL] [Abstract][Full Text] [Related]
5. Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population.
Jara L; Gonzalez-Hormazabal P; Cerceño K; Di Capua GA; Reyes JM; Blanco R; Bravo T; Peralta O; Gomez F; Waugh E; Margarit S; Ibañez G; Romero C; Pakomio J; Roizen G
Breast Cancer Res Treat; 2013 Jan; 137(2):559-69. PubMed ID: 23225170
[TBL] [Abstract][Full Text] [Related]
6. Low-penetrance susceptibility variants and postmenopausal oestrogen receptor positive breast cancer.
Özgöz A; İçduygu FM; Yükseltürk A; ŞamlI H; Öztürk KH; Başkan Z
J Genet; 2020; 99():. PubMed ID: 32366738
[TBL] [Abstract][Full Text] [Related]
7. Association of polymorphisms in intron 2 of FGFR2 and breast cancer risk in Сhinese women.
Pan Z; Bao Y; Zheng X; Cao W; Cheng W; Xu X
Tsitol Genet; 2016; 50(5):59-64. PubMed ID: 30480917
[TBL] [Abstract][Full Text] [Related]
8. Genetic variants in fibroblast growth factor receptor 2 (FGFR2) contribute to susceptibility of breast cancer in Chinese women.
Liang J; Chen P; Hu Z; Zhou X; Chen L; Li M; Wang Y; Tang J; Wang H; Shen H
Carcinogenesis; 2008 Dec; 29(12):2341-6. PubMed ID: 18845558
[TBL] [Abstract][Full Text] [Related]
9. Variants of estrogen-related genes and breast cancer risk in European and African American women.
Quan L; Hong CC; Zirpoli G; Roberts MR; Khoury T; Sucheston-Campbell LE; Bovbjerg DH; Jandorf L; Pawlish K; Ciupak G; Davis W; Bandera EV; Ambrosone CB; Yao S
Endocr Relat Cancer; 2014; 21(6):853-64. PubMed ID: 25228414
[TBL] [Abstract][Full Text] [Related]
10. Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics.
Garcia-Closas M; Hall P; Nevanlinna H; Pooley K; Morrison J; Richesson DA; Bojesen SE; Nordestgaard BG; Axelsson CK; Arias JI; Milne RL; Ribas G; González-Neira A; Benítez J; Zamora P; Brauch H; Justenhoven C; Hamann U; Ko YD; Bruening T; Haas S; Dörk T; Schürmann P; Hillemanns P; Bogdanova N; Bremer M; Karstens JH; Fagerholm R; Aaltonen K; Aittomäki K; von Smitten K; Blomqvist C; Mannermaa A; Uusitupa M; Eskelinen M; Tengström M; Kosma VM; Kataja V; Chenevix-Trench G; Spurdle AB; Beesley J; Chen X; ; ; Devilee P; van Asperen CJ; Jacobi CE; Tollenaar RA; Huijts PE; Klijn JG; Chang-Claude J; Kropp S; Slanger T; Flesch-Janys D; Mutschelknauss E; Salazar R; Wang-Gohrke S; Couch F; Goode EL; Olson JE; Vachon C; Fredericksen ZS; Giles GG; Baglietto L; Severi G; Hopper JL; English DR; Southey MC; Haiman CA; Henderson BE; Kolonel LN; Le Marchand L; Stram DO; Hunter DJ; Hankinson SE; Cox DG; Tamimi R; Kraft P; Sherman ME; Chanock SJ; Lissowska J; Brinton LA; Peplonska B; Klijn JG; Hooning MJ; Meijers-Heijboer H; Collee JM; van den Ouweland A; Uitterlinden AG; Liu J; Lin LY; Yuqing L; Humphreys K; Czene K; Cox A; Balasubramanian SP; Cross SS; Reed MW; Blows F; Driver K; Dunning A; Tyrer J; Ponder BA; Sangrajrang S; Brennan P; McKay J; Odefrey F; Gabrieau V; Sigurdson A; Doody M; Struewing JP; Alexander B; Easton DF; Pharoah PD
PLoS Genet; 2008 Apr; 4(4):e1000054. PubMed ID: 18437204
[TBL] [Abstract][Full Text] [Related]
11. Association of single nucleotide polymorphisms in FGF-RAS/MAP signalling cascade with breast cancer susceptibility.
Dankova Z; Zubor P; Grendar M; Kapinova A; Zelinova K; Jagelkova M; Gondova A; Dokus K; Kalman M; Lasabova Z; Danko J
Gen Physiol Biophys; 2017 Dec; 36(5):565-572. PubMed ID: 29372690
[TBL] [Abstract][Full Text] [Related]
12. Breast cancer susceptibility associated with rs1219648 (fibroblast growth factor receptor 2) and postmenopausal hormone therapy use in a population-based United States study.
Andersen SW; Trentham-Dietz A; Figueroa JD; Titus LJ; Cai Q; Long J; Hampton JM; Egan KM; Newcomb PA
Menopause; 2013 Mar; 20(3):354-8. PubMed ID: 23435034
[TBL] [Abstract][Full Text] [Related]
13. GWAS in the SIGNAL/PHARE clinical cohort restricts the association between the FGFR2 locus and estrogen receptor status to HER2-negative breast cancer patients.
Cox DG; Curtit E; Romieu G; Fumoleau P; Rios M; Bonnefoi H; Bachelot T; Soulié P; Jouannaud C; Bourgeois H; Petit T; Tennevet I; Assouline D; Mathieu MC; Jacquin JP; Lavau-Denes S; Darut-Jouve A; Ferrero JM; Tarpin C; Lévy C; Delecroix V; Trillet-Lenoir V; Cojocarasu O; Meunier J; Pierga JY; Faure-Mercier C; Blanché H; Sahbatou M; Boland A; Bacq D; Besse C; Deleuze JF; Pauporté I; Thomas G; Pivot X
Oncotarget; 2016 Nov; 7(47):77358-77364. PubMed ID: 27764800
[TBL] [Abstract][Full Text] [Related]
14. FGFR2 and other loci identified in genome-wide association studies are associated with breast cancer in African-American and younger women.
Barnholtz-Sloan JS; Shetty PB; Guan X; Nyante SJ; Luo J; Brennan DJ; Millikan RC
Carcinogenesis; 2010 Aug; 31(8):1417-23. PubMed ID: 20554749
[TBL] [Abstract][Full Text] [Related]
15. MYC amplification in subtypes of breast cancers in African American women.
Naab TJ; Gautam A; Ricks-Santi L; Esnakula AK; Kanaan YM; DeWitty RL; Asgedom G; Makambi KH; Abawi M; Blancato JK
BMC Cancer; 2018 Mar; 18(1):274. PubMed ID: 29523126
[TBL] [Abstract][Full Text] [Related]
16. Clinical correlates of low-risk variants in FGFR2, TNRC9, MAP3K1, LSP1 and 8q24 in a Dutch cohort of incident breast cancer cases.
Huijts PE; Vreeswijk MP; Kroeze-Jansema KH; Jacobi CE; Seynaeve C; Krol-Warmerdam EM; Wijers-Koster PM; Blom JC; Pooley KA; Klijn JG; Tollenaar RA; Devilee P; van Asperen CJ
Breast Cancer Res; 2007; 9(6):R78. PubMed ID: 17997823
[TBL] [Abstract][Full Text] [Related]
17. Associations of polymorphisms in the genes of FGFR2, FGF1, and RBFOX2 with breast cancer risk by estrogen/progesterone receptor status.
Cen YL; Qi ML; Li HG; Su Y; Chen LJ; Lin Y; Chen WQ; Xie XM; Tang LY; Ren ZF
Mol Carcinog; 2013 Nov; 52 Suppl 1():E52-9. PubMed ID: 23143756
[TBL] [Abstract][Full Text] [Related]
18. Gene-environment interactions in 7610 women with breast cancer: prospective evidence from the Million Women Study.
Travis RC; Reeves GK; Green J; Bull D; Tipper SJ; Baker K; Beral V; Peto R; Bell J; Zelenika D; Lathrop M;
Lancet; 2010 Jun; 375(9732):2143-51. PubMed ID: 20605201
[TBL] [Abstract][Full Text] [Related]
19. Distribution of FGFR2, TNRC9, MAP3K1, LSP1, and 8q24 alleles in genetically enriched breast cancer patients versus elderly tumor-free women.
Gorodnova TV; Kuligina ESh; Yanus GA; Katanugina AS; Abysheva SN; Togo AV; Imyanitov EN
Cancer Genet Cytogenet; 2010 May; 199(1):69-72. PubMed ID: 20417875
[No Abstract] [Full Text] [Related]
20. Assessing interactions between the associations of fibroblast growth factor receptor 2 common genetic variants and hormone receptor status with breast cancer risk.
Wang H; Yang Z; Zhang H
Breast Cancer Res Treat; 2013 Jan; 137(2):511-22. PubMed ID: 23184080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
